Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of cancer …

Background The efficacy and effectiveness of the quadrivalent human papillomavirus (HPV)
vaccine in preventing high-grade cervical lesions have been shown. However, data to …

Background Cervical screening programmes have reduced cervical cancer incidence and
mortality but the level of success is highly variable between countries. Organisation of …

Objectives To assess whether the increased sensitivity of screening for human papillomavirus
(HPV) may represent overdiagnosis and to compare the long term duration of protective …

Quantitative knowledge of the long‐term human papillomavirus (HPV) type‐specific risks for
high‐grade cervical intraepithelial neoplasias Grades 2 and 3 (CIN2 and CIN3) is useful for …

Background. Decreasing human papillomavirus (HPV) vaccine prices makes scaling up of
vaccination programs attractive for countries that initially targeted 1 or a few birth cohorts of …

Background Human papillomavirus (HPV) vaccination is predicted to lower the positive
predictive value (PPV) of cytology. Methods We included 153,250 girls born between 1989 and …

With major advances in understanding the infectious etiology of cervical cancer, preventive
medicine has obtained highly promising new tools. Human papillomavirus (HPV) vaccines, …

Background High-risk human papillomavirus (hrHPV) infection is established as the major
cause of invasive cervical cancer (ICC). However, whether hrHPV status in the tumor is …

Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19
pandemic led many countries to suspend cancer screening services as part of their …